Trichology to Predict Efficacy of Scalp Cooling: New Pathologic Insights Besides Encouraging Clinical Results

    June 2024 in “ Journal of clinical oncology ”
    Dörthe Schaffrin-Nabe, Anke Josten-Nabe, Andrea Tannapfel … R. Voigtmann
    Studysummary This study found that sensor-controlled scalp cooling prevented visible hair loss in 53% of breast cancer patients undergoing chemotherapy, with greater hair density and absence of comorbidities enhancing its efficacy, also improving patients' quality of life without increasing scalp metastasis risk.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on ascopubs.org →
    Discuss this study in the Community →